35 results on '"Rowland, Laura M."'
Search Results
2. Diffusion-weighted imaging uncovers likely sources of processing-speed deficits in schizophrenia.
- Author
-
Kochunov, Peter, Rowland, Laura M., Eskandar, George, Xiaoming Du, Muellerklein, Florian, Savransky, Anya, Shukla, Dinesh, Sampath, Hemalatha, Hong, L. Elliot, Fieremans, Els, Veraart, Jelle, Jahanshad, Neda, and Thompson, Paul M.
- Subjects
- *
SCHIZOPHRENIA , *DIFFUSION magnetic resonance imaging , *INFORMATION processing , *PEOPLE with schizophrenia , *WHITE matter (Nerve tissue) - Abstract
Schizophrenia, a devastating psychiatric illness with onset in the late teens to early 20s, is thought to involve disrupted brain connectivity. Functional and structural disconnections of cortical networks may underlie various cognitive deficits, including a substantial reduction in the speed of information processing in schizophrenia patients compared with controls. Myelinated white matter supports the speed of electrical signal transmission in the brain. To examine possible neuroanatomical sources of cognitive deficits, we used a comprehensive diffusion-weighted imaging (DWI) protocol and characterized the white matter diffusion signals using diffusion kurtosis imaging (DKI) and permeability-diffusivity imaging (PDI) in patients (n = 74), their nonill siblings (n = 41), and healthy controls (n = 113). Diffusion parameters that showed significant patient-control differences also explained the patient-control differences in processing speed. This associationwas also found for the nonill siblings of the patients. The association was specific to processing-speed abnormality but not specific to working memory abnormality or psychiatric symptoms. Our findings show that advanced diffusion MRI in white matter may capture microstructural connectivity patterns and mechanisms that govern the association between a core neurocognitive measure-- processing speed--and neurobiological deficits in schizophrenia that are detectablewith in vivo brain scans. These non-Gaussian diffusion white matter metrics are promising surrogate imaging markers for modeling cognitive deficits and perhaps, guiding treatment development in schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Schizophrenia clinical symptom differences in women vs. men with and without a history of childhood physical abuse.
- Author
-
Kelly, Deanna L., Rowland, Laura M., Patchan, Kathleen M., Sullivan, Kelli, Earl, Amber, Raley, Heather, Fang Liu, Feldman, Stephanie, and McMahon, Robert P.
- Subjects
- *
CHILD abuse , *RISK factors of schizophrenia in children , *SCHIZOAFFECTIVE disorders , *PSYCHIATRIC rating scales , *NEUROPSYCHOLOGICAL tests - Abstract
Background: Childhood abuse has been implicated as an environmental factor that increases the risk for developing schizophrenia. A recent large population-based case-control study found that abuse may be a risk factor for schizophrenia in women, but not men. Given the sex differences in onset and clinical course of schizophrenia, we hypothesized that childhood abuse may cause phenotypic differences in the disorder between men and women. Methods: We examined the prevalence of childhood physical abuse in a cohort of men and women with schizophrenia and schizoaffective disorder. Specifically, we examined differences in positive, negative, cognitive and depressive symptoms in men and women who reported a history of childhood physical abuse. We recruited 100 subjects for a single visit and assessed a history of childhood physical abuse using the childhood trauma questionnaire (CTQ) and clinical symptoms and cognition using the brief psychiatric rating scale (BPRS), the calgary depression scale (CDS) and the repeatable battery of the assessment of neuropsychological status (RBANS) for cognition. Results: Ninety-two subjects completed the full CTQ with abuse classified as definitely present, definitely absent or borderline. Twelve subjects who reported borderline abuse scores were excluded. Of the 80 subjects whose data was analyzed, 10 of 24 (41.6%) women and 11 of 56 (19.6%) men reported a history of childhood physical abuse (² = 4.21, df = 1, p = 0.04). Women who reported such trauma had significantly more psychotic (sex by abuse interaction; F = 4.03, df = 1.76, p = 0.048) and depressive (F = 4.23, df = 1.76, p = 0.04) symptoms compared to women who did not have a trauma history and men, regardless of trauma history. There were no differences in negative or cognitive symptoms. Conclusions: Women with schizophrenia and schizoaffective disorder may represent a distinct phenotype or subgroup with distinct etiologies and may require different, individually tailored treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.
- Author
-
Chiappelli, Joshua, Rowland, Laura M, Wijtenburg, S Andrea, Muellerklein, Florian, Tagamets, Malle, McMahon, Robert P, Gaston, Frank, Kochunov, Peter, and Hong, L Elliot
- Subjects
- *
MENTAL depression , *INOSITOL , *SCHIZOAFFECTIVE disorders , *AFFECTIVE disorders , *SCHIZOPHRENIA - Abstract
Depression is highly prevalent in patients with schizophrenia and is associated with significant clinical consequences, but there is no known biomarker for depression in schizophrenia. One of the putative neurochemical biomarkers for depression in major depressive disorder (MDD) is reduced cerebral concentration of myo-Inositol. We examined whether myo-Inositol levels provide a potential marker for depressive symptoms in schizophrenia similar to that in MDD and are informative regarding causal biological pathways underlying both depression and schizophrenia. We used proton magnetic resonance spectroscopy to examine myo-Inositol levels in the anterior cingulate cortex (ACC) in 59 schizophrenia spectrum disorder (SSD) patients and 69 matched community comparison participants. Participants completed the Maryland Trait and State Depression (MTSD) scale to measure symptoms of depression experienced around time of assessment ('State' subscale) and longitudinally ('Trait' subscale). Myo-Inositol in the ACC was negatively correlated with MTSD-Trait scores in both patients (ρ=−0.336, p=0.009) and community comparison samples (ρ=−0.328, p=0.006). Furthermore, patients with a diagnosis of schizoaffective disorder or a history of at least one major depressive episode had lower levels of myo-Inositol compared with schizophrenia patients without a current or past affective diagnosis (p=0.012). Since reduced brain myo-Inositol is associated with MDD, myo-Inositol may be a biochemical marker of depressive mood symptoms across diagnostic boundaries. If confirmed, this finding may aid investigation of the pathophysiology and therapeutics of depression common between depression, schizophrenia and other psychiatric diagnoses. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Increased anterior brain activation to correct responses on high-conflict Stroop task in obsessive–compulsive disorder
- Author
-
Ciesielski, Kristina T., Rowland, Laura M., Harris, Richard J., Kerwin, Audra A., Reeve, Alya, and Knight, Jeanne E.
- Subjects
- *
OBSESSIVE-compulsive disorder , *EVOKED potentials (Electrophysiology) , *TASK performance , *STATISTICAL hypothesis testing , *HUMAN information processing , *SCHIZOPHRENIA , *STROOP effect , *PATHOLOGICAL physiology - Abstract
Abstract: Objective: An abnormally increased activation in anterior brain networks, accompanied by normal task performance, has been reported in studies on biological mechanisms of obsessive–compulsive disorder (OCD). We test a hypothesis, that this phenomenon, deemed specific to OCD, will be compromised by a very difficult task, which may lead to reduced cortical information processing and erroneous performance, as found in other disorders such as schizophrenia. Methods: We designed a new variant of high-conflict Stroop-word-color interference task (Stroop-WCIT) with each incongruent (INC) trial preceded by multiple congruent trials. Event-related potentials (ERPs) were acquired from subjects with OCD and case-matched healthy controls (C). We analyzed ERPs elicited by correct responses to conflict-related INC trials. Results: Our hypothesis found no support. Although the anterior ERPs N200, a negative component within 140–300ms latency window, was significantly abnormally increased in OCD subjects, their performance accuracy remained normal. Conclusions: Current findings suggest an enhanced adaptive top-down control in OCD mediated by the prefrontal lateral and dorsal anterior cingulate networks. Significance: Further studies are warranted to test the hypothesis that increased activity within the anterior network for top-down inhibitory control in OCD may be a part of an adaptive compensatory neural mechanism. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
6. The interactive effects of ketamine and nicotine on human cerebral blood flow.
- Author
-
Rowland, Laura M., Beason-Held, Lori, Tamminga, Carol A., and Holcomb, Henry H.
- Subjects
- *
NICOTINE , *CEREBRAL circulation , *KETAMINE , *SMOKING , *BASAL ganglia - Abstract
The purpose of this study was to determine if acute nicotine attenuated ketamine-induced regional cerebral blood flow (rCBF). Following 2–4 h of nicotine abstinence, healthy chronic smokers participated in four sets of rCBF studies, HO positron emission tomography, during a simple sensory motor control task. The four drug conditions studied were placebo, ketamine alone, nicotine alone, and ketamine + nicotine. Intravenous ketamine increased rCBF in frontal, orbital–frontal, and anterior cingulate areas. Nicotine alone induced marked rCBF elevations in the lateral occipital cortex and rCBF suppressions in the basal ganglia and anterior cingulate cortex. Nicotine added to ketamine attenuated the ketamine-induced elevated rCBF in the anterior cingulate cortex but caused a marked rCBF increase in the orbital frontal region. This study illustrates the interactive effects of ketamine, an NMDA receptor antagonist, and nicotine in multiple brain regions. Nicotine substantially ameliorated the effects of ketamine on anterior cingulate rCBF and, when given alone, markedly suppressed anterior cingulate rCBF. The enhanced, synergistic orbitofrontal effects observed with ketamine and nicotine together suggest a marked increase in excitatory neurotransmission in a brain region often linked to psychosis, reward, and addictive behaviors. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. White Matter Alterations in Deficit Schizophrenia.
- Author
-
Rowland, Laura M., Spieker, Elena A., Francis, Alan, Barker, Peter B., Carpenter, William T., and Buchanan, Robert W.
- Subjects
- *
SCHIZOPHRENIA , *DIFFUSION tensor imaging , *NEUROPSYCHOLOGY , *NEUROBIOLOGY , *PROTON magnetic resonance spectroscopy - Abstract
Schizophrenia can be classified into two separate syndromes: deficit and nondeficit. Primary, enduring negative symptoms are used to define the deficit form of the illness, which is believed to have a unique neurobiological substrate. Previous research suggests that an aberrant prefrontal–thalamic–parietal network underlies deficit schizophrenia. In this study we conducted diffusion tensor imaging (DTI) fiber tracking to assess the integrity of the superior longitudinal fasciculus (SLF), the major white matter tract that connects prefrontal and parietal cortical regions, in deficit and nondeficit people with schizophrenia. We also used proton magnetic resonance spectroscopy (1H-MRS) to assess neurochemistry in the left middle prefrontal and left inferior parietal cortical regions. A total of 20 subjects with schizophrenia (10 deficit and 10 nondeficit) and 11 healthy subjects participated in this study. Results revealed reduced fractional anisotropy (FA), an index of white matter integrity, in the right hemisphere SLF and frontal white matter in the deficit subjects. There were no differences in MRS metabolite concentrations among groups. To our knowledge, this is the first DTI study to show compromised integrity of the major white matter tract that connects frontal and parietal regions in deficit schizophrenia. These findings provide further support for altered frontal–parietal network in deficit schizophrenia.Neuropsychopharmacology (2009) 34, 1514–1522; doi:10.1038/npp.2008.207; published online 3 December 2008 [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
8. Proton Magnetic Resonance Spectroscopy During Initial Treatment With Antipsychotic Medication in Schizophrenia.
- Author
-
Bustillo, Juan R., Rowland, Laura M., Jung, Rex, Brooks, William M., Qualls, Clifford, Hammond, Roger, Hart, Blaine, and Lauriello, John
- Subjects
- *
METABOLITES , *SCHIZOPHRENIA , *PSYCHOSES , *ANTIPSYCHOTIC agents , *DRUG utilization , *VOXEL-based morphometry , *MAGNETIC resonance imaging , *NEUROPSYCHOLOGICAL tests - Abstract
Reduced brain N-acetyl-aspartate (NAA) has been repeatedly found in chronic schizophrenia and suggests neuronal loss or dysfunction. However, the potential confounding effect of antipsychotic drugs on NAA has not been resolved. We studied 32 minimally treated schizophrenia patients and 21 healthy subjects with single-voxel proton magnetic resonance spectroscopy (1H-MRS) of the frontal and occipital lobes, caudate nucleus, and cerebellum. Concentrations of NAA, Choline, and Cre were determined and corrected for the proportion of cerebrospinal fluid (CSF) in the voxel. Patients were treated in a randomized-controlled double-blind manner with either haloperidol or quetiapine. 1H-MRS was repeated every 6 months for up to 2 years. There was a group main effect for baseline NAA with lower global NAA in schizophrenia subjects before treatment compared to healthy controls. Global NAA was directly related to measures of global cognitive performance in the whole subject sample. Following treatment with haloperidol or quetiapine, there were no changes in NAA in any of the regions studied. Early in the illness, schizophrenia patients already demonstrate subtle reductions in NAA. Treatment with typical or atypical antipsychotic medications for several months does not result in NAA changes.Neuropsychopharmacology (2008) 33, 2456–2466; doi:10.1038/sj.npp.1301631; published online 19 December 2007 [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Sequential neural changes during motor learning in schizophrenia
- Author
-
Rowland, Laura M., Shadmehr, Reza, Kravitz, Dwight, and Holcomb, Henry H.
- Subjects
- *
POSITRON emission tomography , *SCHIZOPHRENIA , *BLOOD flow , *NEUROPLASTICITY , *MOTOR ability - Abstract
Abstract: Positron emission tomography (PET) was used to investigate differences in neural plasticity associated with learning a unique motor task in patients with schizophrenia and healthy volunteers. Working with a robotic manipulandum, subjects learned reaching movements in a force field. Visual cues were provided to guide the reaching movements. PET rCBF measures were acquired while participants learned the motor skill over successive runs. The groups did not differ in behavioral performance but did differ in their rCBF activity patterns. Healthy volunteers displayed blood flow increases in primary motor cortex and supplementary motor area with motor learning. The patients with schizophrenia displayed an increase in the primary visual cortex with motor learning. Changes in these regions were positively correlated with changes in each group''s motor accuracy, respectively. This is the first study to employ a unique arm-reaching motor learning test to assess neural plasticity during multiple phases of motor learning in patients with schizophrenia. The patients may have an inability to rapidly tune motor cortical neural populations to a preferred direction. The visual system, however, appears to be highly compensated in schizophrenia and the inability to rapidly modulate the motor cortex may be substantially corrected by the schizophrenic group''s visuomotor adaptations. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
10. Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans.
- Author
-
Rowland, Laura M., Astur, Robert S., Jung, Rex E., Bustillo, Juan R., Lauriello, John, and Yeo, Ronald A.
- Subjects
- *
NEUROPSYCHOPHARMACOLOGY , *METHYL aspartate , *COGNITION , *SCHIZOPHRENIA , *MEMORY , *KETAMINE - Abstract
Hypofunction of the N-methyI-D-aspartate receptor (NMDAR) may be involved in the pathophysiology of schizophrenia. NMDAR antagonists like ketamine induce schizophrenia-like features in humans. In rodent studies, NMDAR antagonism impairs learning by disrupting long-term potentiation (LTP) in the hippocampus. This study investigated the effects of ketamine on spatial learning (acquisition) vs retrieval in a virtual Morris water task in humans. Verbal fluency, working memory, and learning and memory of verbal information were also assessed. Healthy human subjects participated in this double-blinded, placebo-controlled study. On two separate occasions, ketamine/placebo was administered and cognitive tasks were assessed in association with behavioral ratings. Ketamine impaired learning of spatial and verbal information but retrieval of information learned prior to drug administration was preserved. Schizophrenia-like symptoms were significantly related to spatial and verbal learning performance. Ketamine did not significantly impair attention, verbal fluency, or verbal working memory task performance. Spatial working memory was slightly impaired. In conclusion, these results provide evidence for ketamine's differential impairment of verbal and spatial learning vs retrieval. By using the Morris water task, which is hippocampal-dependent, this study helps bridge the gap between nonhuman animal and human NMDAR antagonism research. Impaired cognition is a core feature of schizophrenia. A better understanding of NMDA antagonism, its physiological and cognitive consequences, may provide improved models of psychosis and cognitive therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
11. Effects of Ketamine on Anterior Cingulate Glutamate. Metabolism in Healthy Humans: A 4-T Proton MRS Study.
- Author
-
Rowland, Laura M., Bustillo, Juan R., Mullins, Paul G., Jung, Rex E., Lenroot, Rhoshel, Landgraf, Elma, Barrow, Ranee, Yeo, Ronald, Lauriello, John, and Brooks, William M.
- Subjects
- *
KETAMINE , *ANESTHESIA adjuvants , *SCHIZOPHRENIA , *NEUROTRANSMITTERS , *PLACEBOS , *PSYCHIATRIC rating scales - Abstract
Objective: The authors' goal was to test in humans the hypothesis that N-methyl-D-aspartate receptor (NMOAR) antagonism results in increased cortical glutamate activity, as proposed by the NMDAR hypofunction model of schizophrenia. Method: 4-T 1H proton magnetic resonance spectroscopy 1H- MRS) was used to acquire in vivo spectra from the bilateral anterior cingulate of 10 healthy subjects while they received a subanesthetic dose of either placebo or ketamine, an NMDAR antagonist. Assessments given before and after ketamine or placebo administration included the Brief Rating Psychiatric Rating Scale, the Scale for the Assessment of Negative Symptoms, the Clinician-Administered Dissociative States Scale, and the Stroop task. Results: As predicted, there was a significant increase in anterior cingulate glutamine, a putative marker of glutamate neurotransmitter release, with ketamine administration. This increase was not related to schizophrenia-like positive or negative symptoms but was marginally related to Stroop performance. Conclusions: In humans as in animals, an acute hypofunctional NMDAR state is associated with increased glutamatergic activity in the anterior cingulate. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
12. Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.
- Author
-
Nugent, Katie L., Chiappelli, Joshua, Rowland, Laura M., and Hong, L. Elliot
- Subjects
- *
PSYCHOLOGICAL stress , *PATHOLOGICAL physiology , *SCHIZOPHRENIA , *ETIOLOGY of diseases , *SYMPTOMS - Abstract
Summary Background The etiopathophysiology of schizophrenia has long been linked to stress and the influence of stress is important in all stages of the illness. Previous examinations of perceived stress and acute stress responses may not capture this longitudinal stress pathophysiology. We hypothesized that the cumulative negative effects of stress, indexed by allostatic load (AL), would be elevated in schizophrenia, and that the AL paradigm would be relevant to our understanding of pathophysiology in schizophrenia. Methods We assessed allostatic load in 30 patients with schizophrenia (SZ; mean age = 33; 17 males) and 20 healthy controls (HC; mean age = 35; 12 males) using 13 cardiovascular, metabolic, neuroendocrine and immune biomarkers. Participants’ perceived stress over the past month, functional capacity and psychiatric symptoms were also measured. Results Controlling for age, SZ had significantly higher AL as compared to HC ( p = 0.007). Greater AL was present in both early course and chronic SZ, and was associated with reduced functional capacity ( p = 0.006) and more psychotic symptoms ( p = 0.048) in SZ. Current level of perceived stress was not significantly elevated in SZ or associated with AL in either group. Conclusions The higher AL found in SZ may reflect increased bodily “wear and tear”, possibly caused by more chronic stress exposure or maladaptive responses to stress over time, although additional research is required to differentiate these causes. The higher AL is similarly present in early and chronic SZ, suggesting primary maladaptive stress physiology rather than secondary effects from medications or chronic illness. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Distress intolerance and clinical functioning in persons with schizophrenia.
- Author
-
Nugent, Katie L., Chiappelli, Joshua, Rowland, Laura M., Daughters, Stacey B., and Hong, L. Elliot
- Subjects
- *
SCHIZOPHRENIA , *PSYCHOLOGICAL distress , *COGNITION disorders , *PSYCHOLOGICAL resilience , *STRESS tolerance (Psychology) , *MEDIATION (Statistics) ,PSYCHIATRIC research - Abstract
Impaired tolerance to distress may help explain part of the cognitive and functional impairments in schizophrenia (SZ). This project investigated distress intolerance in SZ patients as compared to controls, and whether distress intolerance represented an independent domain in relationship to symptoms, cognition, and functional capacity. Healthy controls ( n =43) and SZ ( n =65) completed a psychological distress challenge experiment and their levels of intolerance to distress were estimated. SZ showed increased distress intolerance such that they were significantly more likely to terminate the distress challenge session early compared to controls. Greater distress intolerance was associated with reduced functional capacity and worse cognitive performance in SZ. Mediation analyses suggested that distress intolerance had an independent effect on functional capacity, while some of this effect was mediated by cognitive performance. Our results suggest that distress intolerance is a promising domain for treatment research, and functional capacity may be improved by targeting treatments towards SZ patient׳s ability to tolerate distress. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Testing the Hypothesis of Accelerated Cerebral White Matter Aging in Schizophrenia and Major Depression
- Author
-
Kochunov, Peter, Glahn, David C., Rowland, Laura M., Olvera, Rene L., Winkler, Anderson, Yang, Yi-Hong, Sampath, Hemalatha, Carpenter, Will T., Duggirala, Ravindranath, Curran, Joanne, Blangero, John, and Hong, L. Elliot
- Subjects
- *
AGING , *BRAIN , *SCHIZOPHRENIA , *MENTAL depression , *DIFFUSION tensor imaging , *ANISOTROPY , *BIOMARKERS , *MYELINATION , *PATHOLOGICAL physiology - Abstract
Background: Elevated rate of aging-related biological and functional decline, termed “accelerated aging,” is reported in patients with schizophrenia (SCZ) and major depressive disorder (MDD). We used diffusion tensor imaging derived fractional anisotropy (FA) as a biomarker of aging-related decline in white matter (WM) integrity to test the hypotheses of accelerated aging in SCZ and MDD. Methods: The SCZ cohort comprised 58 SCZ patients and 60 controls (aged 20–60 years). The MDD cohort comprised 136 MDD patients and 351 controls (aged 20–79 years). The main outcome measures were the diagnosis-by-age interaction on whole-brain-averaged WM FA values and FA values from 12 major WM tracts. Results: Diagnosis-by-age interaction for the whole-brain average FA was significant for the SCZ (p = .04) but not the MDD (p = .80) cohort. Diagnosis-by-age interaction was nominally significant (p<.05) for five WM tracts for SCZ and for none of the tracts in the MDD cohort. Tract-specific heterochronicity of the onset of age-related decline in SCZ demonstrated strong negative correlations with the age-of-peak myelination and the rates of age-related decline obtained from normative sample (r =−.61 and−.80, p<.05, respectively). No such trends existed for MDD cohort. Conclusions: Cerebral WM showed accelerated aging in SCZ but not in MDD, suggesting some difference in the pathophysiology underlying their WM aging changes. Tract-specific heterochronicity of WM development modulated presentation of accelerated aging in SCZ: WM tracts that matured later in life appeared more sensitive to the pathophysiology of SCZ and demonstrated more susceptibility to disorder-related accelerated decline in FA values with age. This trend was not observed in MDD cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.
- Author
-
Bustillo, Juan R., Lauriello, John, Rowland, Laura M., Thomson, Lisa M., Petropoulos, Helen, Hammond, Roger, Hart, Blaine, and Brooks, William M.
- Subjects
- *
SCHIZOPHRENIA , *ANTIPSYCHOTIC agents , *FRONTAL lobe , *COMPARATIVE studies , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *NUCLEAR magnetic resonance spectroscopy , *OCCIPITAL lobe , *RESEARCH , *EVALUATION research , *RANDOMIZED controlled trials , *BLIND experiment ,DRUG therapy for schizophrenia - Abstract
Reduced frontal N-acetylaspartate (NAA) has been repeatedly found in chronic schizophrenia and suggests neuronal loss or dysfunction. However, the potential confounding effect of antipsychotic drugs on NAA has not been resolved. The few studies of antipsychotic-naı̈ve patients are inconclusive. A recent report suggests that antipsychotic drugs may increase NAA in the dorsolateral prefrontal cortex (DLPFC). We studied 10 minimally treated (less than 3 weeks lifetime exposure) schizophrenia patients and 10 normal controls with single-voxel proton magnetic resonance spectroscopy (1H-MRS) of the left frontal and occipital lobes. Concentrations of NAA, Cho, and Cre were determined and corrected for the proportion of cerebrospinal fluid (CSF) in the voxel. Patients were treated in a randomized-controlled double-blind design with either haloperidol or quetiapine. 1H-MRS was repeated within a year. There were no differences in frontal or occipital NAA between patients and controls at baseline. However, frontal NAA was reduced in the schizophrenia group within the first year of treatment. Patients had a clear clinical response to treatment but changes in frontal NAA were not correlated with symptom improvement. The well-described reduced frontal NAA in schizophrenia may not be a trait of the illness but may represent medication effect or progression of the disease. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
16. Sex Differences in Subjective Sleep Quality Patterns in Schizophrenia.
- Author
-
Chen, Michelle H., Korenic, Stephanie A., Wickwire, Emerson M., Wijtenburg, S. Andrea, Hong, L. Elliot, and Rowland, Laura M.
- Subjects
- *
SLEEP , *SLEEP spindles , *SCHIZOPHRENIA , *HYPNOTICS , *PEOPLE with schizophrenia , *HYPNAGOGIA , *WOMEN patients - Abstract
Sleep dysfunction is prevalent among patients with schizophrenia. Although sex differences have been identified in schizophrenia, sex differences in sleep patterns among patients with schizophrenia are not established. Therefore, the current study examined sex differences in subjective sleep quality patterns in people with schizophrenia utilizing a standardized inventory. Study sample consisted of 75 patients with schizophrenia and 82 healthy controls (HC). Participants completed the Pittsburgh Sleep Quality Index (PSQI). Compared to HC, patients with schizophrenia were more likely to report being poor sleepers (PSQI global score > 5), longer sleep duration, more sleep disturbances, longer sleep onset latency, increased daytime dysfunction due to poor sleep, and more frequent use of sleep medications. Regarding sex differences, female patients were more likely to report being poor sleepers and endorsed more sleep disturbances than female HC, while male patients reported longer sleep duration, more daytime dysfunction, and poorer overall sleep quality relative to male HC. Additionally, higher level of sleep dysfunction was linked to higher symptom severity in male patients only. Patients with schizophrenia endorsed a range of sleep difficulties, and male and female patients with schizophrenia differ compared to their HC counterparts. Implications for treatment of sleep complaints among patients with schizophrenia are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia.
- Author
-
Adhikari, Bhim M., Dukart, Juergen, Hipp, Joerg F., Forsyth, Anna, McMillan, Rebecca, Muthukumaraswamy, Suresh D., Ryan, Meghann C., Hong, L. Elliot, Eickhoff, Simon B., Jahandshad, Neda, Thompson, Paul M., Rowland, Laura M., and Kochunov, Peter
- Subjects
- *
MIDAZOLAM , *TRANQUILIZING drugs , *SCHIZOPHRENIA , *FUNCTIONAL magnetic resonance imaging , *PHARMACOLOGY - Abstract
Subanesthetic administration of ketamine is a pharmacological model to elicit positive and negative symptoms of psychosis in healthy volunteers. We used resting‐state pharmacological functional MRI (rsPhfMRI) to identify cerebral networks affected by ketamine and compared them to the functional connectivity (FC) in schizophrenia. Ketamine can produce sedation and we contrasted its effects with the effects of the anxiolytic drug midazolam. Thirty healthy male volunteers (age = 19–37 years) underwent a randomized, three‐way, cross‐over study consisting of three imaging sessions, with 48 hr between sessions. A session consisted of a control period followed by infusion of placebo or ketamine or midazolam. The ENIGMA rsfMRI pipeline was used to derive two long‐distance (seed‐based and dual‐regression) and one local (regional homogeneity, ReHo) FC measures. Ketamine induced significant reductions in the connectivity of the salience network (Cohen's d: 1.13 ± 0.28, p = 4.0 × 10−3), auditory network (d: 0.67 ± 0.26, p =.04) and default mode network (DMN, d: 0.63 ± 0.26, p =.05). Midazolam significantly reduced connectivity in the DMN (d: 0.77 ± 0.27, p =.03). The effect sizes for ketamine for resting networks showed a positive correlation (r =.59, p =.07) with the effect sizes for schizophrenia‐related deficits derived from ENIGMA's study of 261 patients and 327 controls. Effect sizes for midazolam were not correlated with the schizophrenia pattern (r = −.17, p =.65). The subtraction of ketamine and midazolam patterns showed a significant positive correlation with the pattern of schizophrenia deficits (r =.68, p =.03). RsPhfMRI reliably detected the shared and divergent pharmacological actions of ketamine and midazolam on cerebral networks. The pattern of disconnectivity produced by ketamine was positively correlated with the pattern of connectivity deficits observed in schizophrenia, suggesting a brain functional basis for previously poorly understood effects of the drug. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Sleep quality is related to brain glutamate and symptom severity in schizophrenia.
- Author
-
Korenic, Stephanie A., Klingaman, Elizabeth A., Wickwire, Emerson M., Gaston, Frank E., Chen, Hongji, Wijtenburg, S. Andrea, and Rowland, Laura M.
- Subjects
- *
PROTON magnetic resonance spectroscopy , *22Q11 deletion syndrome , *GLUTAMIC acid , *SLEEP - Abstract
Up to 80% of patients with schizophrenia experience sleep disturbances, which negatively impact daytime functioning. Given that the glutamatergic system is involved in the pathophysiology of schizophrenia as well as normal sleep-wake neurobiology, the current project aimed to determine whether sleep quality was related to brain glutamate levels in schizophrenia. The Pittsburgh Sleep Quality Index (PSQI) was used to assess subjective sleep quality and proton magnetic resonance spectroscopy (MRS) was used to quantify glutamate in the bilateral anterior cingulate, left parietal cortex, and left hippocampus. Results indicate that global PSQI scores were negatively correlated with the anterior cingulate and parietal glutamate levels. In patients with schizophrenia, poorer sleep quality correlated with greater positive symptom severity. Our findings suggest that poor sleep quality is related to greater positive symptom severity and lower levels of anterior cingulate glutamate in individuals with schizophrenia. Interventions to enhance sleep quality may prove beneficial for patients. Future studies will examine whether glutamate relates to objective measures of sleep quality, and whether glutamate may mediate the relationship between sleep quality and symptom severity across the schizophrenia-spectrum. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Functional network connectivity impairments and core cognitive deficits in schizophrenia.
- Author
-
Adhikari, Bhim M., Hong, L. Elliot, Sampath, Hemalatha, Chiappelli, Joshua, Jahanshad, Neda, Thompson, Paul M., Rowland, Laura M., Calhoun, Vince D., Du, Xiaoming, Chen, Shuo, and Kochunov, Peter
- Subjects
- *
FUNCTIONAL magnetic resonance imaging , *SCHIZOPHRENIA , *META-analysis , *SHORT-term memory - Abstract
Cognitive deficits contribute to functional disability in patients with schizophrenia and may be related to altered functional networks that serve cognition. We evaluated the integrity of major functional networks and assessed their role in supporting two cognitive functions affected in schizophrenia: processing speed (PS) and working memory (WM). Resting‐state functional magnetic resonance imaging (rsfMRI) data, N = 261 patients and 327 controls, were aggregated from three independent cohorts and evaluated using Enhancing NeuroImaging Genetics through Meta Analysis rsfMRI analysis pipeline. Meta‐ and mega‐analyses were used to evaluate patient‐control differences in functional connectivity (FC) measures. Canonical correlation analysis was used to study the association between cognitive deficits and FC measures. Patients showed consistent patterns of cognitive and resting‐state FC (rsFC) deficits across three cohorts. Patient‐control differences in rsFC calculated using seed‐based and dual‐regression approaches were consistent (Cohen's d: 0.31 ± 0.09 and 0.29 ± 0.08, p < 10−4). RsFC measures explained 12–17% of the individual variations in PS and WM in the full sample and in patients and controls separately, with the strongest correlations found in salience, auditory, somatosensory, and default‐mode networks. The pattern of association between rsFC (within‐network) and PS (r =.45, p =.07) and WM (r =.36, p =.16), and rsFC (between‐network) and PS (r =.52, p = 8.4 × 10−3) and WM (r =.47, p =.02), derived from multiple networks was related to effect size of patient‐control differences in the functional networks. No association was detected between rsFC and current medication dose or psychosis ratings. Patients demonstrated significant reduction in several FC networks that may partially underlie some of the core neurocognitive deficits in schizophrenia. The strength of connectivity‐cognition relationships in different networks was strongly associated with network's vulnerability to schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. White Matter in Schizophrenia Treatment Resistance.
- Author
-
Kochunov, Peter, Huang, Junchao, Chen, Song, Li, Yanli, Tan, Shuping, Fan, Fengmei, Feng, Wei, Wang, Yunhui, Rowland, Laura M., Savransky, Anya, Du, Xiaoming, Chiappelli, Joshua, Chen, Shuo, Jahanshad, Neda, Thompson, Paul M., Ryan, Meghann C., Adhikari, Bhim, Sampath, Hemalatha, Cui, Yimin, and Wang, Zhiren
- Subjects
- *
DIFFUSION tensor imaging , *NEUROLEPTIC malignant syndrome , *SCHIZOPHRENIA , *22Q11 deletion syndrome , *ANTIPSYCHOTIC agents , *AGE of onset - Abstract
Objective: Failure of antipsychotic medications to resolve symptoms in patients with schizophrenia creates a clinical challenge that is known as treatment resistance. The causes of treatment resistance are unknown, but it is associated with earlier age at onset and more severe cognitive deficits. The authors tested the hypothesis that white matter deficits that are involved in both neurodevelopment and severity of cognitive deficits in schizophrenia are associated with a higher risk of treatment resistance.Methods: The study sample (N=122; mean age, 38.2 years) included schizophrenia patients at treatment initiation (N=45), patients whose symptoms were treatment responsive (N=40), and patients whose symptoms were treatment resistant (N=37), as well as healthy control subjects (N=78; mean age, 39.2 years). White matter regional vulnerability index (RVI) was tested as a predictor of treatment resistance and cognitive deficits. Higher RVI is indicative of better agreement between diffusion tensor imaging fractional anisotropy across the brain in an individual and the pattern identified by the largest-to-date meta-analysis of white matter deficits in schizophrenia.Results: Patients with treatment-resistant symptoms showed the highest white matter RVI (mean=0.38 [SD=0.2]), which was significantly higher than the RVI among patients with treatment-responsive symptoms (mean=0.30 [SD=0.02]). At the onset of treatment, schizophrenia patients showed significantly higher RVI than healthy control subjects (mean=0.18 [SD=0.03] and mean=0.13 [SD=0.02], respectively). RVIs were significantly correlated with performance on processing speed and negative symptoms.Conclusions: Schizophrenia affects white matter microstructure in specific regional patterns. Susceptibility to white matter regional deficits is associated with an increased likelihood of treatment resistance. Developments to overcome schizophrenia treatment resistance should consider white matter as an important target. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
21. Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia.
- Author
-
Shovestul, Bridget J., Glassman, Matthew, Rowland, Laura M., Mcmahon, Robert P., Liu, Fang, and Kelly, Deanna L.
- Subjects
- *
SCHIZOPHRENIA treatment , *KYNURENINE , *EMOTIONAL trauma in children , *PERCEIVED Stress Scale , *HIGH performance liquid chromatography , *THERAPEUTICS - Published
- 2017
- Full Text
- View/download PDF
22. A working memory related mechanism of auditory hallucinations.
- Author
-
Gaudiot, Christopher, Xiaoming Du, Summerfelt, Ann, Hare, Stephanie M., Bustillo, Juan R., Rowland, Laura M., Hong, L. Elliot, and Du, Xiaoming
- Subjects
- *
AUDITORY hallucinations , *SHORT-term memory , *FACTOR analysis , *PEOPLE with schizophrenia , *SCHIZOPHRENIA - Abstract
Cognitive mechanisms underlying auditory hallucinations (AH) in schizophrenia have been related to working memory (WM), although the formative mechanism is unknown. The phonological loop refers to subvocal rehearsals of information held online for supporting WM. As WM deficiency is frequent in schizophrenia, we hypothesized that AH and WM deficit share a common dysfunction in phonological loop operation, especially when it is taxed by ambiguous auditory and verbal associations. We developed an active phonological priming (APP) paradigm in which participants generated arbitrary verbal associations to pseudowords with ambiguous meaning. They were later asked to rate their familiarity to each pseudoword, a task that required subvocal evaluation of ambiguous auditory-verbal information. Factor and mediation analyses were used to test the hypothesis that WM, AH, and APP induced phonological bias toward perceiving ambiguous contents as familiar may share a common underlying mechanism. In 32 patients with schizophrenia (SZ) and 20 healthy controls (HC), SZ rated ambiguous pseudowords as significantly more familiar compared with HC (p = .006), indicating a proneness to APP-induced bias. This increased subjective bias to perceive ambiguous contents as familiar after APP significantly correlated with AH severity (p = .001) and mediated the relationship between WM and AH. Factor analysis demonstrated a common latent factor among WM, AH, and the bias induced by active priming to ambiguous contents. A heightened phonological loop priming to ambiguous contents appears to be mechanistically linked to WM deficits and AH in schizophrenia. These findings emphasize the importance of jointly addressing WM deficits and AH in clinical practice and research. (PsycINFO Database Record (c) 2019 APA, all rights reserved). [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.
- Author
-
Wijtenburg, S. Andrea, Kapogiannis, Dimitrios, Korenic, Stephanie A., Mullins, Roger J., Tran, Joyce, Gaston, Frank E., Chen, Shuo, Mustapic, Maja, Hong, L. Elliot, and Rowland, Laura M.
- Subjects
- *
INSULIN resistance , *MEMORY , *NUCLEAR magnetic resonance spectroscopy , *GLUCOSE , *BRAIN , *VERBAL learning ,BRAIN metabolism - Abstract
Memory is robustly impaired in schizophrenia (SZ) and related to functional outcome. Memory dysfunction has been shown to be related to altered brain glucose metabolism and brain insulin resistance in animal models and human studies of Alzheimer's disease. In this study, differences in brain glucose using magnetic resonance spectroscopy (MRS) and blood Extracellular Vesicle (EV) biomarkers of neuronal insulin resistance (i.e. Akt and signaling effectors) between SZ and controls were investigated, as well as whether these measures were related to memory impairments. Neuronal insulin resistance biomarkers showed a trend for being lower in SZ compared to controls, and memory measures were lower in SZ compared to controls. Occipital cortex glucose was higher in SZ compared to controls indicating lower brain glucose utilization. Linear regression analyses revealed significant relationships between neuronal insulin resistance biomarkers, memory measures, and brain glucose. More specifically, p70S6K, an insulin signaling effector, was related to verbal learning and brain MRS glucose in the SZ group. For the first time, we show that memory impairments in SZ may be related to brain glucose and brain insulin resistance. These data suggest that brain insulin resistance may play a role in the pathophysiology of learning and memory dysfunction in SZ. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.
- Author
-
Du, Xiaoming, Choa, Fow-Sen, Chiappelli, Joshua, Wisner, Krista M., Wittenberg, George, Adhikari, Bhim, Bruce, Heather, Rowland, Laura M., Kochunov, Peter, and Hong, L. Elliot
- Subjects
- *
PREFRONTAL cortex , *MOTOR cortex , *SCHIZOPHRENIA , *TRANSCRANIAL magnetic stimulation , *MICROSTRUCTURE - Abstract
Abstract Background Inhibitory deficits in motor cortex in schizophrenia have been well demonstrated using short-interval intracortical inhibition (SICI) by transcranial magnetic stimulation. However, it remains unknown whether these deficits originate from dysfunction of motor cortex itself or reflect abnormal modulations of motor cortex by other schizophrenia-related brain areas. Methods The study was completed by 24 patients with schizophrenia spectrum disorders and 30 healthy control subjects. SICI was obtained by delivering transcranial magnetic stimulation over the left motor cortex. Resting-state functional magnetic resonance imaging and diffusion tensor imaging fractional anisotropy were used to measure functional connectivity (FC) and white matter microstructures, respectively. Stimulation sites for SICI at motor cortex were used as the seeds to obtain whole-brain FC maps. Clinical symptoms were assessed with the Brief Psychiatric Rating Scale. Results In schizophrenia, left prefrontal cortex–motor cortex FC was inversely associated with SICI but positively associated with the underlying white matter microstructure at the left corona radiata and also associated with overall symptoms (all corrected p <.05). Mediation analysis showed that the prefrontal-motor cortex FC significantly mediated the corona radiata white matter effects on SICI (p =.007). Conclusions Higher resting-state left prefrontal-motor cortex FC, accompanied by a higher fractional anisotropy of left corona radiata, predicted fewer inhibitory deficits, suggesting that the inhibitory deficits in motor cortex in schizophrenia may in part be mediated by a top-down prefrontal influence. SICI may serve as a robust biomarker indexing inhibitory dysfunction at anatomic as well as circuitry levels in schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Allostatic load and reduced cortical thickness in schizophrenia.
- Author
-
Chiappelli, Joshua, Kochunov, Peter, Savransky, Anya, Fisseha, Feven, Wisner, Krista, Du, Xiaoming, Rowland, Laura M., and Hong, L. Elliot
- Subjects
- *
SCHIZOPHRENIA , *ALLOSTASIS , *CEREBRAL cortex anatomy , *PSYCHOLOGICAL stress , *BIOMARKERS - Abstract
Structural imaging studies have consistently found reduced gray matter thickness of the cerebral cortex in schizophrenia, a finding that is evident in first episode psychosis and may be progressive in some cases. Although genetic predisposition and medication effects may contribute to cortical thinning, we hypothesize that the cumulative effects of stress may represent an environmental factor impacting brain morphology in schizophrenia. We examined the relationship between allostatic load, an index of peripheral biomarkers representing the cumulative effects of stress, and cortical thickness. Allostatic load was calculated for 44 patients with schizophrenia spectrum disorders (SSD) and 33 normal controls (NC) based on 13 cardiovascular, neuroendocrine, immune, and metabolic measurements. Controlling for age, SSD had significantly elevated allostatic load as compared with NC (p = 0.008). Controlling for age, whole brain average cortical thickness was lower in SSD patients compared to NC (p = 0.008). However, once allostatic load was accounted for, the group difference in cortical thickness became marginal (p = 0.058). Exploratory analyses on subcomponents of allostatic load suggested that elevated immune marker C-reactive protein, stress hormones, and cardiovascular indices within allostatic load were more strongly associated with reduced cortical thickness in SSD. In NC, only the association between immune marker C-reactive protein and cortical thickness was replicated. These results support the hypothesis that allostatic load may account for some of the gray matter deficits observed in schizophrenia. Among the allostatic indices, the inflammatory mechanism appears particularly relevant to cortical thickness in both schizophrenia patients and normal controls. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
26. Regarding “Increased Prefrontal and Hippocampal Glutamate Concentration in Schizophrenia: Evidence from a Magnetic Resonance Spectroscopy Study”
- Author
-
Théberge, Jean, Jensen, J. Eric, and Rowland, Laura M.
- Published
- 2007
- Full Text
- View/download PDF
27. Disrupted glucocorticoid—Immune interactions during stress response in schizophrenia.
- Author
-
Chiappelli, Joshua, Shi, Qiaoyun, Kodi, Priyadurga, Savransky, Anya, Kochunov, Peter, Rowland, Laura M., Nugent, Katie L., and Hong, L. Elliot
- Subjects
- *
SCHIZOPHRENIA , *GLUCOCORTICOIDS , *IMMUNE system , *PSYCHOLOGICAL stress , *HYDROCORTISONE , *INTERLEUKINS - Abstract
Glucocorticoid and immune pathways typically interact dynamically to optimize adaptation to stressful environmental challenges. We tested the hypothesis that a dysfunctional glucocorticoid–immune relationship contributes to abnormal stress response in schizophrenia. Saliva samples from 34 individuals with schizophrenia (20 male, 14 female) and 40 healthy controls (20 male, 20 female) were collected prior to and at 3 time points following completion of a computerized psychological challenge meant to be frustrating. Salivary concentrations of cortisol and interleukin-6 (IL-6) and their response to the challenge were examined. Both cortisol and IL-6 significantly increased in response to stress in the combined sample (both p < .05). In controls, the rise in cortisol following the challenge was negatively correlated to the subsequent changes in IL-6 ( r = −.461, p = .003), such that rise of cortisol immediately after stress predicts subsequently lower IL-6 levels. In contrast, this relationship was positive in schizophrenia patients ( r = .379, p = .027). The trends were significantly different ( Z = 3.7, p = .0002). This stress paradigm induces a rise in both cortisol and IL-6. In healthy controls, a more robust acute cortisol response was associated with a steeper decline of IL-6 levels following stress, corresponding to the expected anti-inflammatory effects of cortisol. Patients exhibited the opposite relationship, suggesting an inability to down-regulate inflammatory responses to psychological stress in schizophrenia; or even a paradoxical increase of IL-6 response. This finding may partially underlie abnormalities in inflammatory and stress pathways previously found in the illness, implicating dysregulated stress response in the chronic inflammatory state in schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: Application to schizophrenia.
- Author
-
Wijtenburg, S. Andrea, Yang, Shaolin, Fischer, Bernard A., and Rowland, Laura M.
- Subjects
- *
NEUROTRANSMITTERS , *IMMUNOMODULATORS , *NUCLEAR magnetic resonance spectroscopy , *SCHIZOPHRENIA treatment , *GLUTAMIC acid , *MAGNETIC flux density , *BIOMARKERS , *DISEASE exacerbation - Abstract
In vivo measurement of neurotransmitters and modulators is now feasible with advanced proton magnetic resonance spectroscopy ( 1 H MRS) techniques. This review provides a basic tutorial of MRS, describes the methods available to measure brain glutamate, glutamine, γ-aminobutyric acid, glutathione, N -acetylaspartylglutamate, glycine, and serine at magnetic field strengths of 3 T or higher, and summarizes the neurochemical findings in schizophrenia. Overall, 1 H MRS holds great promise for producing biomarkers that can serve as treatment targets, prediction of disease onset, or illness exacerbation in schizophrenia and other brain diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis.
- Author
-
Alvarado-Alanis, Patricia, León-Ortiz, Pablo, Reyes-Madrigal, Francisco, Favila, Rafael, Rodríguez-Mayoral, Oscar, Nicolini, Humberto, Azcárraga, Mariana, Graff-Guerrero, Ariel, Rowland, Laura M., and de la Fuente-Sandoval, Camilo
- Subjects
- *
WHITE matter (Nerve tissue) , *ANTIPSYCHOTIC agents , *PSYCHOSES , *DIFFUSION tensor imaging , *PEOPLE with schizophrenia , *BRAIN abnormalities , *ANISOTROPY , *PATIENTS - Abstract
Introduction Diffusion tensor imaging (DTI) studies in patients with schizophrenia have shown abnormalities in the microstructure of white matter tracts. Specifically, reduced fractional anisotropy (FA) has been described across multiple white matter tracts, in studies that have mainly included patients treated with antipsychotic medications. Objective To compare FA in antipsychotic-naïve patients experiencing a first episode of psychosis (FEP) to FA in healthy controls to demonstrate that the variance of FA can be grouped, in a coincidental manner, in four predetermined factors in accordance with a theoretical partition of the white matter tracts, using a principal components analysis (PCA). Methods Thirty-five antipsychotic-naïve FEP patients and 35 age- and gender-matched healthy controls underwent DTI at 3 T. Analysis was performed using a tract-based spatial statistics (TBSS) method and exploratory PCA. Results DTI analysis showed extensive FA reduction in white matter tracts in FEP patients compared with the control group. The PCA grouped the white matter tracts into four factors explaining 66% of the total variance. Comparison of the FA values within each factor highlighted the differences between FEP patients and controls. Discussion Our study confirms extensive white matter tracts anomalies in patients with schizophrenia, more specifically, in drug-naïve FEP patients. The results also indicate that a small number of white matter tracts share common FA anomalies that relate to deficit symptoms in FEP patients. Our study adds to a growing body of literature emphasizing the need for treatments targeting white matter function and structure in FEP patients. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. Accelerated white matter aging in schizophrenia: role of white matter blood perfusion.
- Author
-
Wright, Susan N., Kochunov, Peter, Chiappelli, Joshua, McMahon, Robert P., Muellerklein, Florian, Wijtenburg, S. Andrea, White, Michael G., Rowland, Laura M., and Hong, L. Elliot
- Subjects
- *
WHITE matter (Nerve tissue) , *AGING , *ETIOLOGY of schizophrenia , *DIAGNOSIS of schizophrenia , *PEOPLE with schizophrenia , *BLOOD circulation - Abstract
Elevated rate of age-related decline in white matter integrity, indexed by fractional anisotropy (FA) from diffusion tensor imaging, was reported in patients with schizophrenia. Its etiology is unknown. We hypothesized that a decline of blood perfusion to the white matter may underlie the accelerated age-related reduction in FA in schizophrenia. Resting white matter perfusion and FA were collected using pseudo-continuous arterial spin labeling and high-angular-resolution diffusion tensor imaging, respectively, in 50 schizophrenia patients and 70 controls (age = 18-63 years). Main outcome measures were the diagnosis-by-age interaction on whole-brain white matter perfusion, and FA. Significant age-related decline in brain white matter perfusion and FA were present in both groups. Age-by-diagnosis interaction was significant for FA (p < 0.001) but not white matter perfusion. Age-by-diagnosis interaction for FA values remained significant even after accounting for age-related decline in perfusion. Therefore, we replicated the finding of an increased rate of age-related white matter FA decline in schizophrenia and observed a significant age-related decline in white matter blood perfusion, although the latter did not contribute to the accelerated age-related decline in FA. The results suggest that factors other than reduced perfusion account for the accelerated age-related decline in white matter integrity in schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
31. Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia.
- Author
-
Kochunov, Peter, Chiappelli, Joshua, Wright, Susan N., Rowland, Laura M., Patel, Beenish, Wijtenburg, S. Andrea, Nugent, Katie, McMahon, Robert P., Carpenter, William T., Muellerklein, Florian, Sampath, Hemalatha, and Hong, L. Elliot
- Subjects
- *
WHITE matter (Nerve tissue) , *BRAIN imaging , *ANISOTROPY , *SCHIZOPHRENIA , *PERMEABILITY , *BRAIN physiology - Abstract
We hypothesized that reduced fractional anisotropy (FA) of water diffusion and its elevated aging-related decline in schizophrenia patients may be caused by elevated hyperintensive white matter (HWM) lesions, by reduced permeability-diffusivity index (PDI), or both. We tested this hypothesis in 40/30 control/patient participants. FA values for the corpus callosum were calculated from high angular resolution diffusion tensor imaging (DTI). Whole-brain volume of HWM lesions was quantified by 3D-T2w-fluid-attenuated inversion recovery (FLAIR) imaging. PDI for corpus callosum was ascertained using multi b-value diffusion imaging (15 b-shells with 30 directions per shell). Patients had significantly lower corpus callosum FA values, and there was a significant age-by-diagnosis interaction. Patients also had significantly reduced PDI but no difference in HWM volume. PDI and HWM volume were significant predictors of FA and captured the diagnosis-related variance. Separately, PDI robustly explained FA variance in schizophrenia patients, but not in controls. Conversely, HWM volume made equally significant contributions to variability in FA in both groups. The diagnosis-by-age effect of FA was explained by a PDI-by-diagnosis interaction. Post hoc testing showed a similar trend for PDI of gray mater. Our study demonstrated that reduced FA and its accelerated decline with age in schizophrenia were explained by pathophysiology indexed by PDI, rather than HWM volume. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Facilitation of Relational Learning in Schizophrenia.
- Author
-
Spieker, Elena A., Griego, Jacqueline A., Astur, Robert S., Holcomb, Henry H., and Rowland, Laura M.
- Subjects
- *
SCHIZOPHRENIA , *HIPPOCAMPUS physiology , *LEARNING , *PSYCHOLOGICAL research ,HUMAN behavior research - Abstract
Abnormal hippocampal function likely contributes to relational learning deficits observed in schizophrenia. It is unknown whether these deficits can be attenuated with a training intervention. The purpose of this project was to determine if training could facilitate relational learning of the transverse patterning task in schizophrenia. Healthy and schizophrenia subjects completed a version of transverse patterning that incorporated training. The majority of subjects with schizophrenia successfully learned transverse patterning when provided with training. A subgroup (approximately 25%) of schizophrenia subjects showed no tendency to learn with training. These results were replicated in a second study with a separate cohort and different stimuli. This study illustrates that relational learning of the transverse patterning can be facilitated in schizophrenia with training. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
33. Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia
- Author
-
Spieker, Elena A., Astur, Robert S., West, Jeffrey T., Griego, Jacqueline A., and Rowland, Laura M.
- Subjects
- *
SCHIZOPHRENIA , *SPATIAL memory , *VIRTUAL reality , *COGNITION disorders , *SHORT-term memory , *MENTAL illness - Abstract
Abstract: Learning and memory impairments are present in schizophrenia (SZ) throughout the illness course and predict psychosocial function. Abnormalities in prefrontal and hippocampal function are thought to contribute to SZ deficits. The radial arm maze (RAM) is a test of spatial learning and memory in rodents that relies on intact prefrontal and hippocampal function. The goal of the present study was to investigate spatial learning in SZ using a virtual RAM. Thirty-three subjects with SZ and thirty-nine healthy controls (HC) performed ten trials of a virtual RAM task. Subjects attempted to learn to retrieve four rewards each located in separate arms. As expected, subjects with SZ used more time and traveled more distance to retrieve rewards, made more reference (RM) and working memory (WM) errors, and retrieved fewer rewards than HC. It is important to note that the SZ group did learn but did not reach the level of HC. Whereas RM errors decreased across trials in the SZ group, WM errors did not. There were no significant relationships between psychiatric symptom severity and maze performance. To our knowledge, use of a virtual 8-arm radial maze task in SZ to assess spatial learning is novel. Impaired virtual RAM performance in SZ is consistent with studies that examined RAM performance in animal models of SZ. Results provide further support for compromised prefrontal and hippocampal function underlying WM and RM deficits in SZ. The virtual RAM task could help bridge preclinical and clinical research for testing novel drug treatments of SZ. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
34. Lower glutamate level in temporo-parietal junction may predict a better response to tDCS in schizophrenia.
- Author
-
Lee, Junhee, Yoon, Youngwoo Bryan, Wijtenburg, S. Andrea, Rowland, Laura M., Chen, Hongji, Gaston, Frank E., Song, In Chan, Cho, Kang Ik K., Kim, Minah, Lee, Tae Young, and Kwon, Jun Soo
- Subjects
- *
SCHIZOPHRENIA , *GLUTAMIC acid , *SCHIZOPHRENIA treatment , *PARIETAL lobe , *MENTAL illness , *GLUTAMIC acid metabolism , *COMPARATIVE studies , *HALLUCINATIONS , *RESEARCH methodology , *MEDICAL cooperation , *HEALTH outcome assessment , *PROTON magnetic resonance spectroscopy , *RESEARCH , *TEMPORAL lobe , *EVALUATION research , *TRANSCRANIAL direct current stimulation - Published
- 2018
- Full Text
- View/download PDF
35. Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls✰,✰✰,★,★★.
- Author
-
Huang, Junchao, Zhu, Yu, Fan, Fengmei, Chen, Song, Hong, Yuan, Cui, Yimin, Luo, Xingguang, Tan, Shuping, Wang, Zhiren, Shang, Lan, Yuan, Ying, Zhang, Jianxin, Yang, Fude, Li, Chiang-Shan R., Rowland, Laura M., Kochunov, Peter, Zhang, Fengyu, Hong, L. Elliot, and Tan, Yunlong
- Subjects
- *
ARIPIPRAZOLE , *HIPPOCAMPUS (Brain) , *SHORT-term memory , *LOGISTIC regression analysis , *SCHIZOPHRENIA , *COGNITIVE ability - Abstract
• Deficits in all domains of cognition and hippocampal volume in patients with treatment-resistant schizophrenia as compared to healthy control group. • Only poorer performances in working memory and smaller total hippocampal volume in patients with treatment-resistant schizophrenia by comparisons with matched treatment-responsive patients. • Working memory deficits and smaller hippocampal volume contribute to higher risk of treatment resistance, but not their interactions. Some patients with schizophrenia do not respond to pharmacotherapy. More severe cognitive dysfunctions have been associated with treatment-resistant schizophrenia (TRS). This study examines cognitive functions and hippocampal volumes in 43 patients with TRS and compared them to 43 treatment-responsive patients (NTRS), matched on age, sex and education, as well as 53 healthy controls (HC). The results showed that there were significant deficits in all domains of cognition and hippocampal volumes in TRS as compared to HC group. However, TRS specific deficits, as indicated by comparisons with matched NTRS, were limited to poorer performance in working memory (p = 0.003) and smaller total hippocampal volume (p = 0.01). Logistic regression analysis showed that working memory deficits [ OR 0.94 (95% CI 0.89–0.98), p = 0.005] and smaller hippocampal volume [ OR 0.89 (95% CI 0.81–0.97), p = 0.01], but not their interactions (p = 0.68), contributed to higher risk of treatment resistance. The findings suggest that treatment-resistance to currently available antipsychotic medications may not be due to global cognitive deficits in these patients, but be associated with specific deficits in working memory and hippocampus deficits in the subgroup of schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.